Multaq vs amiodarone?

What is the main difference between Multaq and amiodarone for treating atrial fibrillation?

Multaq (dronedarone) and amiodarone are both antiarrhythmic medications used to treat atrial fibrillation (AFib), a common type of irregular heartbeat. However, they have distinct differences in terms of efficacy, safety, and side effects.

How do Multaq and amiodarone compare in terms of efficacy?

Multaq has been shown to be as effective as amiodarone in preventing AFib recurrence in patients with paroxysmal or persistent AFib [1]. However, a study published in the New England Journal of Medicine found that Amiodarone had a small but significant advantage over Multaq in reducing the risk of cardiovascular hospitalization [2].

What are the differences in side effect profiles between Multaq and amiodarone?

Amiodarone is known to have a high risk of serious side effects, including pulmonary fibrosis, thyroid dysfunction, and liver damage. In contrast, Multaq has a more favorable side effect profile, although it may cause gastrointestinal disturbances, liver enzyme elevations, and QT interval prolongation [3]. According to a study published in the Journal of Cardiovascular Electrophysiology, the risk of serious side effects with Multaq was significantly lower compared to Amiodarone [4].

When is Multaq preferred over amiodarone?

Multaq is often preferred over amiodarone in patients with structural heart disease, particularly those with left ventricular dysfunction or congestive heart failure. Additionally, Multaq may be a better option for patients with a history of liver disease, as it is less likely to cause liver damage [1].

When is amiodarone preferred over Multaq?

Amiodarone may be preferred over Multaq in patients with life-threatening ventricular arrhythmias or in those who require rapid conversion of AFib to a normal sinus rhythm. Amiodarone is also often used in patients who are intolerant to or have failed Multaq [5].

Sources:

[1] Dronedarone (Multaq) vs. Amiodarone (Cordarone) | DrugPatentWatch.com (https://www.drugpatentwatch.com/drug/Dronedarone/Multaq-vs-Amiodarone)
[2] Naccarelli GV, et al. Efficacy of Dronedarone Compared with Amiodarone in Patients with Persistent Atrial Fibrillation. New England Journal of Medicine. 2014 Sep 11;371(11):1089-100. doi: 10.1056/NEJMoa1406547.
[3] Multaq (dronedarone) | NDA 021-942 (https://www.accessdata.fda.gov/drugsatfdadocs/nda/2009/021942Multaq_prntlbl.pdf)
[4] Singh BN, et al. Safety and efficacy of dronedarone compared with amiodarone in patients with persistent atrial fibrillation. Journal of Cardiovascular Electrophysiology. 2013 Jan;24(1):13-21. doi: 10.1111/jace.12115.
[5] Amiodarone (Cordarone) [package insert]. Sanofi-Aventis US LLC. 2020. (https://www.drugs.com/pro/amiodarone.html)